Medicare Enrolled

Dr. Tarek Eldawy, M.D.

Hematology & Oncology · Oviedo, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
2572 W STATE ROAD 426 STE 3080, Oviedo, FL 32765
4075658389
In practice since 2006 (19 years)
NPI: 1669416459 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eldawy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eldawy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eldawy

Dr. Tarek Eldawy is a hematology & oncology in Oviedo, FL, with 19 years in practice. Based on federal Medicare data, Dr. Eldawy performed 11,781 Medicare services across 1,365 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eldawy received a total of $46,938 from 69 pharmaceutical and/or device companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eldawy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 26% volume in FL$ $46,938 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,781
Medicare services
Top 26% in FL for hematology & oncology
1,365
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~620 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)8,100$0$5
Denosumab injection (Prolia/Xgeva)1,560$19$51
Office visit, established patient (30-39 min)576$73$135
Office visit, established patient (20-29 min)539$49$112
Blood draw (venipuncture)229$8$9
Complete blood count (CBC) with differential213$8$29
Drug injection, under skin or into muscle132$11$69
Hospital follow-up visit, moderate complexity68$63$182
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg56$1$6
Office visit, established patient (10-19 min)52$20$42
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less48$49$189
New patient office visit (45-59 min)47$111$258
Hospital follow-up visit, high complexity36$96$264
New patient office visit (30-44 min)31$71$193
Office visit, established patient, complex (40-54 min)27$123$335
Initial hospital admission, moderate complexity26$102$352
Injection of drug or substance into vein23$29$156
Initial hospital admission, high complexity18$133$534
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
83.8% medium
15.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$46,938
Total received (2018-2024)
Avg $6,705/year across 7 years
Top 15% in FL for hematology & oncology
69
Companies
448
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$28,195 (60.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,475 (20.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,848 (16.7%)
Other
Charitable contributions, space rental, and other categories
$1,419 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,631
2023
$7,802
2022
$4,843
2021
$295
2020
$3,148
2019
$16,516
2018
$5,701

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$15,275
E.R. Squibb & Sons, L.L.C.
$5,751
PFIZER INC.
$4,476
ABBVIE INC.
$3,985
Lilly USA, LLC
$3,947
Ipsen Biopharmaceuticals, Inc
$2,436
Novartis Pharmaceuticals Corporation
$1,767
Bayer HealthCare Pharmaceuticals Inc.
$1,590
Celgene Corporation
$771
Incyte Corporation
$534
Eisai Inc.
$434
Merck Sharp & Dohme LLC
$406
Alexion Pharmaceuticals, Inc.
$314
Genentech USA, Inc.
$305
Janssen Biotech, Inc.
$281
Amgen Inc.
$265
Daiichi Sankyo Inc.
$251
Merck Sharp & Dohme Corporation
$244
Puma Biotechnology, Inc.
$240
Stemline Therapeutics Inc.
$217
Gilead Sciences, Inc.
$201
GENZYME CORPORATION
$199
Janssen Scientific Affairs, LLC
$181
SOBI, INC
$167
Regeneron Healthcare Solutions, Inc.
$164
Bayer Healthcare Pharmaceuticals Inc.
$144
Myovant Sciences Inc.
$144
Biocompatibles, Inc.
$121
Blueprint Medicines Corporation
$118
Novocure Inc.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$110
Boston Scientific Corporation
$108
PharmaEssentia USA Corporation
$104
SERVIER PHARMACEUTICALS LLC
$95
AbbVie, Inc.
$94
Genmab U.S., Inc.
$81
Astellas Pharma US Inc
$78
TerSera Therapeutics LLC
$74
Pharmacosmos Therapeutics Inc.
$70
Seagen Inc.
$68
Epizyme, Inc.,
$64
BeiGene USA, Inc.
$60
JAZZ PHARMACEUTICALS INC.
$60
GlaxoSmithKline, LLC.
$55
ADC Therapeutics America, Inc.
$54
SpringWorks Therapeutics, Inc.
$51
G1 Therapeutics, Inc.
$46
Menarini Silicon Biosystems, Inc.
$44
Agios Pharmaceuticals, Inc.
$43
Mirati Therapeutics, Inc.
$43
Rigel Pharmaceuticals, Inc.
$41
ARRAY BIOPHARMA INC
$39
Fennec Pharmaceuticals, Inc.
$34
Janssen Pharmaceuticals, Inc
$33
Octapharma USA, Inc.
$33
Kite Pharma, Inc.
$33
EMD Serono, Inc.
$31
Karyopharm Therapeutics Inc.
$27
Sirtex Medical Inc
$26
Foundation Medicine, Inc.
$26
Tempus AI, Inc
$25
Exelixis Inc.
$24
Dendreon Pharmaceuticals LLC
$23
TAIHO ONCOLOGY, INC.
$23
MorphoSys, US Inc.
$20
Deciphera Pharmaceuticals Inc.
$16
Kyowa Kirin, Inc.
$16
PUMA BIOTECHNOLOGY, INC.
$15
Adaptive Biotechnologies Corporation
$12
Top 3 companies account for 54.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BESREMI · BOSULIF · BRUKINSA · Blincyto · CABOMETYX · COSELA · CUTAQUIG · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FRUZAQLA · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · Jivi · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · MYLOTARG · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rituxan · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · Stivarga · TAGRISSO · TAZVERIK · THERASPHERE - BIO · TIVDAK · Tazverik · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Tibsovo · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Venclexta · Vitrakvi · XARELTO · XPOVIO · XT CDX · XTANDI · Xtandi · Yescarta · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $398 per 100 Medicare services performed
Looking for a hematology & oncology in Oviedo?
Compare hematology & oncologys in the Oviedo area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
44
Per 100K population
9.3
County median income
$83,030
Nearest hospital
OVIEDO MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Eldawy is a mixed practice specialist, with above-average Medicare volume (top 26% in FL), and high industry engagement (consulting-driven, top 15%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Eldawy experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Eldawy performed 8,100 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eldawy receive payments from pharmaceutical companies?
Yes. Dr. Eldawy received a total of $46,938 from 69 companies across 448 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eldawy's costs compare to other hematology & oncologys in Oviedo?
Dr. Eldawy's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eldawy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →